Trading Signals: ADAP Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Fri. May. 28, 2021)(Adaptimmune Therapeutics plc)
| ADAP latest price $8.5200 (-2.07%) ($8.3000 - $8.8900) on Tue. Sep. 1, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.94% (three month average) | RSI | 60 | Latest Price | $8.5200(-2.07%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ADAP declines -0.4% a day on average for past five trading days. | Weekly Trend | ADAP advances 0.1% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ADAP advance at 0% a week (0% probability) XLRE(26%) DRIV(23%) IWC(23%) IWM(22%) IWN(21%) | Factors Impacting ADAP price | ADAP will decline at least -1.97% in a week (0% probabilities). BNDX(-15%) TLT(-12%) VXX(-9%) TIP(-9%) BND(-9%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.97% (StdDev 3.94%) | Hourly BBV | 0 () | Intraday Trend | -0.8% | | | |
|
5 Day Moving Average | $8.33(2.28%) | 10 Day Moving Average | $8.48(0.47%) | 20 Day Moving Average | $8.37(1.79%) | To recent high | -29.6% | To recent low | 8.4% | Market Cap | $1.317b | | | | Adaptimmune Therapeutics Plc engages in the development of novel cancer immunotherapy products. Its specific peptide enhanced affinity receptor platform enables the engineering of T-cells to target and destroy cancer, including solid tumors. The company was founded by Bent K. Jakobsen, James Julian Noble, and Helena Katrina Tayton-Martin in 2008 and is headquartered in Abingdon, the United Kingdom. |